Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun;43(3):76-77.
doi: 10.18773/austprescr.2020.030. Epub 2020 Apr 22.

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic

Ian Coombes  1   2   3 , Alexandra Markwell  1   2   3 , Paul Kubler  1   2   3 , Andrew M Redmond  1   2   3 , Gordon McGurk  1   2   3 , Jason A Roberts  1   2   3
Affiliations
Editorial

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic

Ian Coombes et al. Aust Prescr. 2020 Jun.
No abstract available

Keywords: COVID-19; ethics; hydroxychloroquine.

PubMed Disclaimer

Conflict of interest statement

Ian Coombes is the Director of the Royal Brisbane and Women’s Hospital pharmacy department, which has an interim licence to support pharmacy activities associated with COVID-19 clinical trials, including the Australasian COVID-19 Trial (ASCOT) involving hydroxychloroquine. Andrew Redmond is an associate investigator and Jason Roberts is an investigator on the ASCOT study. Funding for this study has come from donors and the authors do not receive any financial advantage for their participation. Paul Kubler is principal site investigator for Abbvie for two phase III trials on drugs for psoriatic arthritis and systemic lupus erythematosus. He does not receive any financial benefit for participation. Funding goes to a public hospital research trust fund.

References

    1. Thomas K, Grady D. Trump’s embrace of unproven drugs to treat coronavirus defies science. New York Times 2020 Mar 20. https://www.nytimes.com/2020/03/20/health/ coronavirus-chloroquine-trump... [cited 2020 Mar 20]
    1. Kim AH, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, et al. COVID-19 Global Rheumatology Alliance† A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 2020; . 10.7326/M20-1223 - DOI - PMC - PubMed
    1. Adaptive COVID-19 Treatment Trial. ClinicalTrials.gov identifier: NCT04280705. First posted 2020 Feb 21. https://clinicaltrials.gov/ct2/show/NCT04280705?term=rem desivir&cond=covid-19&draw=2&rank=5 [cited 2020 Mar 20]
    1. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010;69:20-8. . 10.1136/ard.2008.101766 - DOI - PubMed
    1. The Council of Australian Therapeutic Advisory Groups. Rethinking medicines decision-making in Australian hospitals: guiding principles for the quality use of off-label medicines. Sydney: CATAG; 2013. http://www.catag.org.au/rethinking-medicines-decision-making-2/ [cited 2020 Apr 20]

Publication types

LinkOut - more resources